WallStSmart
LLY

Eli Lilly and Company

NYSE: LLY · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

$1,210.02
-0.87% today

Updated 2026-07-29

Market cap
$1.02T
P/E ratio
41.83
P/S ratio
14.35x
EPS (TTM)
$27.80
Dividend yield
0.53%
52W range
$619 – $1,249
Volume
3.0M

Eli Lilly and Company (LLY) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for LLY.

WallStSmart Verdict
Attractively
Valued

Fundamentals support the current valuation. Strong combination of growth, quality, and price.

Smart Value Score: 76 / 100
P/E (TTM)
41.8x
vs 5Y median of 42.7x
PEG
1.58
Fair range
Margin of Safety
DCF limited for this profile
EV / EBITDA
30.0x

LLY historical valuation range

Where current P/E sits in LLY's own 5Y range.

NOW
34.3x
5Y Low
40.2x
25th
42.7x
Median
51.5x
75th
114.6x
5Y High
LLY is trading cheaper than 60% of the last 5Y.
40th percentile · Below median

LLY intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

DCF has limited applicability for LLY

Standard discounted cash flow models produce unreliable output for unprofitable or near-breakeven companies. Revenue-based multiples such as P/S and EV/Sales, combined with the historical valuation position above, give a more reliable read for this stock.

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

LLY valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

!
PEG in fair range
PEG of 1.58 suggests price reflects growth fairly. Neither a bargain nor overpriced.
!
P/E in mid-range
P/E sits at the 40th percentile of the 5Y range. Neither cheap nor rich historically.
!
DCF limited applicability
Company profile produces unstable DCF output. Lean on P/S, EV/Sales, and historical valuation position instead of intrinsic value for this stock.

P/E Ratio — History

Current: 41.83x

P/S Ratio — History

Current: 14.35x

Is LLY overvalued in 2026?

Eli Lilly and Company (LLY) currently trades at $1,210.02 per share with a market capitalization of $1,022,738,235,000.00. Based on our multi-factor framework, the stock looks attractively valued with a Smart Value Score of 76/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

The stock trades at a P/E ratio of 41.8x, below its 5-year median of 42.7x. The PEG ratio of 1.58 points to a price that reasonably reflects expected earnings growth.

Looking at its own history, LLY is currently trading cheaper than 60% of the last 5Y on P/E. This places it in the 40th percentile of its historical range, a reasonable but unremarkable position.

A standard DCF model does not produce reliable output for LLY under current conditions. For unprofitable or near-breakeven companies, revenue-based multiples such as EV/Sales and historical P/S percentile are more informative than intrinsic value calculations.

The Piotroski F-Score of 6/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: LLY looks attractively valued on our framework, with a Smart Value Score of 76/100. The combination of reasonable price, healthy growth, and quality fundamentals makes it worth serious consideration.

Frequently asked questions

Is LLY overvalued?

LLY scores 76/100 on our Smart Value Score (Grade B+), a strong overall profile. A standard DCF is unreliable here given the profitability profile, so valuation leans on revenue-based measures like EV/Sales and the P/S percentile below.

What is LLY's fair value?

A standard DCF is unreliable for LLY given its current profitability profile. Revenue-based approaches like EV/Sales or the historical P/S percentile are more informative for this stock.

What P/E ratio does LLY trade at?

LLY trades at a P/E of 41.8x on trailing twelve-month earnings, against a 5-year median of 42.7x. P/E is what you pay per dollar of profit, and sitting below its own median means the stock is cheaper than usual relative to its earnings.

Is LLY a buy based on valuation?

Our Smart Value rating for LLY is Buy, from a Smart Value Score of 76/100 that blends growth, quality, and valuation. The rating leans on growth and financial strength, and valuation is usually the weakest leg for a name scoring this high. This is research to inform your decision, not personalized financial advice.

How does LLY's valuation compare to its history?

On P/E, LLY sits in the 40th percentile of its own 5Y range, below its long-run median relative to where it has traded. A low percentile means today's multiple is near the bottom of its historical band.

What is LLY's Smart Value Score?

LLY's Smart Value Score is 76/100. It is a proprietary WallStSmart metric blending growth quality, financial health, and valuation into a single 0-100 read, and scores above 75 are rare, signaling strong multi-factor alignment.